Curaleaf Holdings Inc
(TSX:CURA)
C$
13.22
-0.36 (-2.65%)
Market Cap: 3.50 Bil
Enterprise Value: 4.63 Bil
PE Ratio: 0
PB Ratio: 2.88
GF Score: 75/100 
Q2 2026 Curaleaf Holdings Inc Earnings Call Transcript
Aug 05, 2026 / 09:00PM GMT
Release Date Price:
C$11.71
(-7.36%)
Key Points
Positve
- Curaleaf Holdings Inc (CURLF) delivered strong Q2 2026 results with revenue of $340 million, a 10% organic year-over-year increase, surpassing guidance and internal projections.
- The company achieved significant profitability improvements, with net income of $12.5 million compared to a net loss of $48 million in the prior-year period, and gross margin expanded to 50%.
- Domestic business regained momentum with 7% year-over-year growth, driven by broad-based strength across key markets like Ohio, Utah, New York, Florida, and Maryland, and a 500-basis-point sequential acceleration.
- International segment grew 26% year-over-year, led by strong performance in the UK, Germany, and Poland, and the company completed the buyout of the remaining 45% minority interest in Four20 Pharma for full control.
- The company is well-positioned for future growth with the anticipated closure of the hemp loophole, potential federal rescheduling of adult-use cannabis, and expansion into new markets like Georgia, Texas, and Virginia.
- Operational excellence is evident with a 10% increase in retail transactions, 28% growth in branded wholesale sales, and continued margin expansion despite price compression.
- Curaleaf Holdings Inc (CURLF) is executing a substantial cost reduction program expected to save $35-40 million in SG&A over the next 12 months, enhancing profitability and cash flow.
- The company is preparing for potential uplisting to a major US exchange, having completed a reverse split and received shareholder approval for re-domiciliation to the US.
- Regulatory tailwinds, including the reclassification of medical cannabis to Schedule III, are expected to reduce tax burdens and improve access to financial services.
- The company is strategically increasing vertical integration in international markets to 50-75%, which is expected to improve margins and reduce inventory levels.
Negative
- Curaleaf Holdings Inc (CURLF) faces ongoing price compression in key markets, particularly in Germany and the US, which could pressure margins if not managed carefully.
- The company's international segment experienced a 140-basis-point drag on adjusted EBITDA margin due to its nascent growth curve and supply chain volatility.
- Core SG&A expenses increased by $15 million year-over-year, with core SG&A as a percentage of revenue rising 200 basis points to 34%, partly due to higher bonus accruals and international expansion.
- The company's inventory levels increased 10% year-over-year, with international inventory up 50% due to lumpy third-party deliveries, impacting cash conversion.
- Curaleaf Holdings Inc (CURLF) faces potential risks from global macro volatility, higher energy costs, and rising interest rates, which could impact consumer demand.
- The company's Q3 2026 revenue guidance of low single-digit sequential growth implies a slowdown from Q2, reflecting seasonality in key states like Florida and Arizona.
- The company is exposed to supply chain inefficiencies in international markets, with only 20% of supply coming from its own facilities, leading to higher inventory and cash conversion days.
- Price compression in Germany, particularly at the lower end, could intensify, and the company's strategy of focusing on premium brands may limit volume growth.
- The company's domestic growth is partially offset by declines in Arizona and Illinois, indicating uneven performance across markets.
- The potential for competitors to engage in aggressive discounting could impact Curaleaf Holdings Inc (CURLF)'s ability to maintain pricing and margins.
Operator
Good day, and welcome to the Curaleaf Holdings, Inc., second-quarter 2026 conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Camilo Lyon, Chief Investment Officer. Please go ahead.
Camilo Lyon
Curaleaf Holdings, Inc - Chief Investment Officer
Good afternoon, everyone, and welcome to Curaleaf Holdings' second-quarter 2026 conference call. Today, I'm joined by Chairman and Chief Executive Officer, Boris Jordan; President, Rahul Pinto; and Chief Financial Officer, Ed Kremer.
Before we begin, I'd like to remind everyone that the comments on today's call will include forward-looking statements within the meaning of Canadian and United States securities laws, which, by their nature, involve estimates, projections, plans, goals, forecasts, and assumptions, including the successful integration of acquisitions, and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers